Literature DB >> 7522030

Endotoxin is angiogenic.

I Mattsby-Baltzer1, A Jakobsson, J Sörbo, K Norrby.   

Abstract

The formation of new blood vessels, angiogenesis, is an important event in inflammation, wound healing and tumour growth. Mediators produced by various cells when exposed to endotoxin include cytokines (tumour necrosis factor, interleukins 1 and 6, and basic fibroblast growth factor) which, it has been suggested, stimulate angiogenesis. The angiogenic effect of endotoxin (lipopolysaccharide, LPS) was studied in rats using the quantitative mesenteric window assay. Adult rats were injected intraperitoneally with Escherichia coli LPS (5 pg/ml-20,000 ng/ml) twice daily for 4.5 consecutive days and were sacrificed 14 days after the start of this treatment. An angiogenic response was observed at concentrations of > 2 ng/ml in a dose-dependent manner. No inflammatory cellular exudate was seen in the test tissue at the time of angiogenesis analysis. Suppressed body-weight gain, a marker of the systemic effect of LPS in the rat, was significant only at the highest dose tested. The data suggest that endotoxin-mediated neovascularization could be a component of inflammation and wound healing.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7522030      PMCID: PMC2001811     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  22 in total

Review 1.  Diverse receptors for fibroblast growth factors.

Authors:  J Partanen; S Vainikka; J Korhonen; E Armstrong; K Alitalo
Journal:  Prog Growth Factor Res       Date:  1992

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Mast-cell-mediated angiogenesis: a novel experimental model using the rat mesentery.

Authors:  K Norrby; A Jakobsson; J Sörbo
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1986

Review 4.  Angiogenic factors.

Authors:  J Folkman; M Klagsbrun
Journal:  Science       Date:  1987-01-23       Impact factor: 47.728

Review 5.  Endotoxins and disease mechanisms.

Authors:  D C Morrison; J L Ryan
Journal:  Annu Rev Med       Date:  1987       Impact factor: 13.739

6.  Cellular and extracellular changes following mast-cell secretion in avascular rat mesentery. An electron-microscopic study.

Authors:  K Norrby; S Eneström
Journal:  Cell Tissue Res       Date:  1984       Impact factor: 5.249

7.  Species differences in Kupffer cells and endotoxin sensitivity.

Authors:  R S McCuskey; P A McCuskey; R Urbaschek; B Urbaschek
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

8.  A physico-chemical comparison of the monocyte-derived fibroblast growth factor and the tumour necrosis factor.

Authors:  R Austgulen; J Nissen-Meyer
Journal:  APMIS       Date:  1988-04       Impact factor: 3.205

9.  Dual role of tumor necrosis factor-alpha in angiogenesis.

Authors:  L F Fajardo; H H Kwan; J Kowalski; S D Prionas; A C Allison
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

10.  Histamine content of peritoneal and tissue mast cells of growing rats.

Authors:  L Enerbäck; U Wingren
Journal:  Histochemistry       Date:  1980
View more
  13 in total

1.  Lipopolysaccharide-induced proliferation of the vasa vasorum in a rabbit model of atherosclerosis as evaluated by contrast-enhanced ultrasound imaging and histology.

Authors:  Jinwei Tian; Sining Hu; Xue Han; Nana Dong; Huai Yu; Yanli Sun; Bo Yu
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

2.  VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2.

Authors:  Chul Han; Se-Woon Choe; Yong Hwan Kim; Abhinav P Acharya; Benjamin G Keselowsky; Brian S Sorg; Young-Jae Lee; S Paul Oh
Journal:  Angiogenesis       Date:  2014-06-24       Impact factor: 9.596

Review 3.  Consensus guidelines for the use and interpretation of angiogenesis assays.

Authors:  Patrycja Nowak-Sliwinska; Kari Alitalo; Elizabeth Allen; Andrey Anisimov; Alfred C Aplin; Robert Auerbach; Hellmut G Augustin; David O Bates; Judy R van Beijnum; R Hugh F Bender; Gabriele Bergers; Andreas Bikfalvi; Joyce Bischoff; Barbara C Böck; Peter C Brooks; Federico Bussolino; Bertan Cakir; Peter Carmeliet; Daniel Castranova; Anca M Cimpean; Ondine Cleaver; George Coukos; George E Davis; Michele De Palma; Anna Dimberg; Ruud P M Dings; Valentin Djonov; Andrew C Dudley; Neil P Dufton; Sarah-Maria Fendt; Napoleone Ferrara; Marcus Fruttiger; Dai Fukumura; Bart Ghesquière; Yan Gong; Robert J Griffin; Adrian L Harris; Christopher C W Hughes; Nan W Hultgren; M Luisa Iruela-Arispe; Melita Irving; Rakesh K Jain; Raghu Kalluri; Joanna Kalucka; Robert S Kerbel; Jan Kitajewski; Ingeborg Klaassen; Hynda K Kleinmann; Pieter Koolwijk; Elisabeth Kuczynski; Brenda R Kwak; Koen Marien; Juan M Melero-Martin; Lance L Munn; Roberto F Nicosia; Agnes Noel; Jussi Nurro; Anna-Karin Olsson; Tatiana V Petrova; Kristian Pietras; Roberto Pili; Jeffrey W Pollard; Mark J Post; Paul H A Quax; Gabriel A Rabinovich; Marius Raica; Anna M Randi; Domenico Ribatti; Curzio Ruegg; Reinier O Schlingemann; Stefan Schulte-Merker; Lois E H Smith; Jonathan W Song; Steven A Stacker; Jimmy Stalin; Amber N Stratman; Maureen Van de Velde; Victor W M van Hinsbergh; Peter B Vermeulen; Johannes Waltenberger; Brant M Weinstein; Hong Xin; Bahar Yetkin-Arik; Seppo Yla-Herttuala; Mervin C Yoder; Arjan W Griffioen
Journal:  Angiogenesis       Date:  2018-08       Impact factor: 9.596

Review 4.  Surgery for Cancer: A Trigger for Metastases.

Authors:  Samer Tohme; Richard L Simmons; Allan Tsung
Journal:  Cancer Res       Date:  2017-03-22       Impact factor: 12.701

Review 5.  The influence of the commensal microbiota on distal tumor-promoting inflammation.

Authors:  Claire M Buchta Rosean; Melanie R Rutkowski
Journal:  Semin Immunol       Date:  2017-07-04       Impact factor: 11.130

6.  Recombinant bactericidal permeability increasing protein (rBPI21) inhibits surgery-induced tumour growth in a murine model of metastatic disease.

Authors:  G T O'Donoghue; G P Pidgeon; J H Harmey; R Dedrick; H P Redmond; D J Bouchier-Hayes
Journal:  Ir J Med Sci       Date:  2008-10-15       Impact factor: 1.568

7.  Endothelial immune activation programmes cell-fate decisions and angiogenesis by inducing angiogenesis regulator DLL4 through TLR4-ERK-FOXC2 signalling.

Authors:  Sheng Xia; Heather L Menden; Thomas R Korfhagen; Tsutomu Kume; Venkatesh Sampath
Journal:  J Physiol       Date:  2018-03-02       Impact factor: 5.182

8.  The role of endotoxin/lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic disease.

Authors:  G P Pidgeon; J H Harmey; E Kay; M Da Costa; H P Redmond; D J Bouchier-Hayes
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

9.  Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells.

Authors:  G P Pidgeon; M P Barr; J H Harmey; D A Foley; D J Bouchier-Hayes
Journal:  Br J Cancer       Date:  2001-07-20       Impact factor: 7.640

10.  Targeting glioblastoma via intranasal administration of Ff bacteriophages.

Authors:  Eyal Dor-On; Beka Solomon
Journal:  Front Microbiol       Date:  2015-05-27       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.